User profiles for Sarah A Almahboub
 | Sarah AlmahboubAssociate Research Scientist, KAIMRC Verified email at kaimrc.edu.sa Cited by 386 |
SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients
As the Coronavirus Disease 2019 (COVID-19), which is caused by the novel SARS-CoV-2,
continues to spread rapidly around the world, there is a need for well validated serological …
continues to spread rapidly around the world, there is a need for well validated serological …
Unnatural amino acids: production and biotechnological potential
Unnatural amino acids (UAAs) are valuable building blocks in the manufacture of a wide
range of pharmaceuticals. UAAs exhibit biological activity as free acids and they can be …
range of pharmaceuticals. UAAs exhibit biological activity as free acids and they can be …
Early humoral response correlates with disease severity and outcomes in COVID-19 patients
The Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, continues to spread
globally with significantly high morbidity and mortality rates. Antigen-specific responses are of …
globally with significantly high morbidity and mortality rates. Antigen-specific responses are of …
Evaluation of neutralizing antibodies against highly pathogenic coronaviruses: a detailed protocol for a rapid evaluation of neutralizing antibodies using vesicular …
SA Almahboub, A Algaissi, MA Alfaleh… - Frontiers in …, 2020 - frontiersin.org
Emerging highly pathogenic human coronaviruses (CoVs) represent a serious ongoing threat
to the public health worldwide. The spike (S) proteins of CoVs are surface glycoproteins …
to the public health worldwide. The spike (S) proteins of CoVs are surface glycoproteins …
[HTML][HTML] Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016
…, AS Almasoud, M Mousa, SA Almahboub… - Journal of infection and …, 2020 - Elsevier
Background The Middle East respiratory syndrome coronavirus (MERS-CoV) is a newly
recognized zoonotic coronavirus. Current evidence confirms the role of dromedaries in primary …
recognized zoonotic coronavirus. Current evidence confirms the role of dromedaries in primary …
[HTML][HTML] Construction of VSVΔ51M oncolytic virus expressing human interleukin-12
…, E Ghazal, AA Alsaieedi, SA Almahboub… - Frontiers in Molecular …, 2023 - frontiersin.org
The use of oncolytic viruses (OVs) in combination with cytokines, such as IL-12, is a
promising approach for cancer treatment that addresses the limitations of current standard …
promising approach for cancer treatment that addresses the limitations of current standard …
Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity
SA Almahboub, T Narancic, M Devocelle… - Applied microbiology …, 2018 - Springer
Terminal modification of peptides is frequently used to improve their hydrophobicity. While N-terminal
modification with fatty acids (lipidation) has been reported previously, C-terminal …
modification with fatty acids (lipidation) has been reported previously, C-terminal …
ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks
MA Alfaleh, RM Alsulaiman, SA Almahboub… - Antibody …, 2024 - academic.oup.com
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and the Middle East
respiratory syndrome coronavirus (MERS-CoV) are highly pathogenic human coronaviruses (…
respiratory syndrome coronavirus (MERS-CoV) are highly pathogenic human coronaviruses (…
Single point mutations reveal amino acid residues important for Chromobacterium violaceum transaminase activity in the production of unnatural amino acids
Unnatural amino acids (UAAs) are chiral amines with high application potential in drug
discovery and synthesis of other valuable chemicals. Biocatalysis offers the possibility to …
discovery and synthesis of other valuable chemicals. Biocatalysis offers the possibility to …
Synthetic SARS-CoV-2 spike-based DNA vaccine elicits robust and long-lasting th1 humoral and cellular immunity in mice
…, M Basabrain, A Algaissi, S Almahboub… - Frontiers in …, 2021 - frontiersin.org
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) calls for an urgent
development of effective and safe prophylactic and therapeutic measures. The spike (S) …
development of effective and safe prophylactic and therapeutic measures. The spike (S) …
